Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

760 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort.
Montanari S, Jansen R, Schranner D, Kastenmüller G, Arnold M, Janiri D, Sani G, Bhattacharyya S, Dehkordi SM, Dunlop BW, Rush AJ, Penninx BWHJ, Kaddurah-Daouk R, Milaneschi Y. Montanari S, et al. Among authors: rush aj. medRxiv [Preprint]. 2024 Feb 15:2024.02.14.24302813. doi: 10.1101/2024.02.14.24302813. medRxiv. 2024. PMID: 38405847 Free PMC article. Preprint.
Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials.
Vreijling SR, Chin Fatt CR, Williams LM, Schatzberg AF, Usherwood T, Nemeroff CB, Rush AJ, Uher R, Aitchison KJ, Köhler-Forsberg O, Rietschel M, Trivedi MH, Jha MK, Penninx BWJH, Beekman ATF, Jansen R, Lamers F. Vreijling SR, et al. Among authors: rush aj. Br J Psychiatry. 2024 Mar;224(3):89-97. doi: 10.1192/bjp.2023.148. Br J Psychiatry. 2024. PMID: 38130122 Free PMC article.
Metabolomics Signatures of serotonin reuptake inhibitor (Escitalopram), serotonin norepinephrine reuptake inhibitor (Duloxetine) and Cognitive Behavior Therapy on Key Neurotransmitter Pathways in Major Depressive Disorder.
Bhattacharyya S, MahmoudianDehkordi S, Sniatynski MJ, Belenky M, Marur VR, Rush AJ, Craighead WE, Mayberg HS, Dunlop BW, Kristal BS, Kaddurah-Daouk R; Mood Disorder Precision Medicine Consortium. Bhattacharyya S, et al. Among authors: rush aj. medRxiv [Preprint]. 2024 Apr 3:2024.04.02.24304677. doi: 10.1101/2024.04.02.24304677. medRxiv. 2024. PMID: 38633777 Free PMC article. Preprint.
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report.
Conway CR, Aaronson ST, Sackeim HA, Duffy W, Stedman M, Quevedo J, Allen RM, Riva-Posse P, Berger MA, Alva G, Malik MA, Dunner DL, Cichowicz I, Luing H, Zajecka J, Nahas Z, Mickey BJ, Kablinger AS, Kriedt CL, Bunker MT, Lee YL, Shy O, Majewski S, Olin B, Tran Q, Rush AJ. Conway CR, et al. Among authors: rush aj. Brain Stimul. 2024 Mar-Apr;17(2):448-459. doi: 10.1016/j.brs.2024.03.016. Epub 2024 Apr 2. Brain Stimul. 2024. PMID: 38574853 Free article. Clinical Trial.
The STAR*D Data Remain Strong: Reply to Pigott et al.
Rush AJ, Trivedi M, Fava M, Thase M, Wisniewski S. Rush AJ, et al. Am J Psychiatry. 2023 Dec 1;180(12):919-920. doi: 10.1176/appi.ajp.20230869. Am J Psychiatry. 2023. PMID: 38037409 No abstract available.
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: II. Sensitivity to treatment effects.
Aaronson ST, Sackeim HA, Jiang M, Badejo S, Greco T, Bunker MT, Conway CR, Demyttenaere K, Young AH, McAllister-Williams RH, Rush AJ. Aaronson ST, et al. Among authors: rush aj. Aust N Z J Psychiatry. 2024 Mar;58(3):250-259. doi: 10.1177/00048674231209837. Epub 2023 Nov 5. Aust N Z J Psychiatry. 2024. PMID: 37927051 Free PMC article.
760 results